UPDATE 1-Bristol-Myers lung cancer delay slams shares, keeps Merck in lead
New YORK, Jan 20 (Reuters) - Bristol-Myers Squibb Co shares fell 11 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its immunotherapy drug... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: shares, its immunotherapy, approval, accelerated, would, Thursday's announcement, following, percent, Squibb, Bristol-Myers, (Reuters), Merck, keeps, slams, delay, cancer, 1-Bristol-Myers, UPDATE
Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/k_-kctmhuHk/bristol-myers-cancer-idUSL1N1FA1R9